Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected6M Return
Four symbols is the limit; remove one to add another.
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | BIAF | PFE | MRNA |
|---|---|---|---|---|
| Return | ||||
| Last Price | 54.70 | 18.39 | 28.49 | 146.05 |
| Daily Change | — | + 43.90% | − 1.10% | − 1.89% |
| Period ReturnPast 6 Months | — | + 12.10% | + 4.98% | + 181.28% |
| Valuation | ||||
| Market Cap | $4.50 B | $3.24 M | $162 B | $58.0 B |
| P/E Ratio | — | — | — | — |
| Dividend Yield | — | — | — | — |
| Net MarginTrailing 12M | — | 257.3% | — | 141.4% |
| Risk | ||||
| Beta | — | -1.36 | — | 1.22 |
| 52-Week Range | — | 4.56 — $202.50 | — | 22.28 — $176.66 |
| Company | ||||
| Sector | — | — | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology | Pharmaceuticals | Biotechnology |
Company
- AKROBiotechnology
- BIAFBiotechnology
- PFEHealth Care · Pharmaceuticals
- MRNAHealth Care · Biotechnology
Metrics could not be loaded for AKRO, PFE: P/E, dividend, beta and the 52-week range stay empty in that column.
Alpaca · SIPUpdated 21:5915 Minutes Delayed
To Understand This